• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[掌腱膜挛缩症:病理生理学的知识与研究现状]

[Dupuytren's disease: state of knowledge and research in physiopathology].

作者信息

Carvalhana G, Auquit-Auckbur I, Milliez P-Y

机构信息

Service de chirurgie plastique et de la main, CHU de Rouen, 4, rue de Germont, 76000 Rouen, France.

出版信息

Chir Main. 2011 Sep;30(4):239-45. doi: 10.1016/j.main.2011.03.002. Epub 2011 Apr 28.

DOI:10.1016/j.main.2011.03.002
PMID:21592840
Abstract

From Baron Dupuytren's historical description up to the advent of molecular biology, many hypotheses about the etiology of Dupuytren's disease have been proposed. This bibliography of the last ten years' publications describes tissue anomalies from the macroscopic down to the ultrastructural level of pathology. The myofibroblast, which is the principal cell of the disease, is the seat of genetics anomalies involving proto-oncogenes (c-myc and MafB). Similarly, glycoproteins implicated in cellular adhesion like fibronectins and catenins are modified and overexpressed in the disease. Extracellular proteins of the metalloproteinase family exhibit many dysfunctions responsible for collagenic proliferation. Finally, growth factors like Transforming Growth Factor (TGF) and Epidermal Growth Factor (EGF) receptor maintain and worsen the disease and could be therapeutic targets in the future.

摘要

从迪皮特朗男爵的历史描述到分子生物学的出现,人们提出了许多关于迪皮特朗病病因的假说。这份过去十年出版物的参考文献描述了从宏观到病理学超微结构水平的组织异常。肌成纤维细胞是该病的主要细胞,是涉及原癌基因(c-myc和MafB)的基因异常所在。同样,参与细胞黏附的糖蛋白如纤连蛋白和连环蛋白在该病中发生修饰并过度表达。金属蛋白酶家族的细胞外蛋白表现出许多导致胶原增殖的功能障碍。最后,转化生长因子(TGF)和表皮生长因子(EGF)受体等生长因子维持并加重该病,可能成为未来的治疗靶点。

相似文献

1
[Dupuytren's disease: state of knowledge and research in physiopathology].[掌腱膜挛缩症:病理生理学的知识与研究现状]
Chir Main. 2011 Sep;30(4):239-45. doi: 10.1016/j.main.2011.03.002. Epub 2011 Apr 28.
2
Cellular structure and biology of Dupuytren's disease.掌腱膜挛缩症的细胞结构与生物学特性
Hand Clin. 1999 Feb;15(1):21-34.
3
Epidermal growth factor receptor (EGF-R) in Dupuytren's disease.掌腱膜挛缩症中的表皮生长因子受体(EGF-R)
J Hand Surg Br. 2005 Dec;30(6):570-3. doi: 10.1016/j.jhsb.2005.06.008. Epub 2005 Aug 2.
4
Transforming growth factor-beta: possible roles in Dupuytren's contracture.
J Hand Surg Am. 1995 Jan;20(1):101-8. doi: 10.1016/S0363-5023(05)80067-X.
5
Transforming growth factor-beta1 stimulation enhances Dupuytren's fibroblast contraction in response to uniaxial mechanical load within a 3-dimensional collagen gel.转化生长因子-β1刺激可增强掌腱膜成纤维细胞在三维胶原凝胶中对单轴机械负荷的收缩反应。
J Hand Surg Am. 2009 Jul-Aug;34(6):1102-10. doi: 10.1016/j.jhsa.2009.02.008. Epub 2009 Jun 7.
6
Tamoxifen decreases fibroblast function and downregulates TGF(beta2) in dupuytren's affected palmar fascia.他莫昔芬可降低掌腱膜挛缩症患者掌腱膜中纤维母细胞的功能,并下调转化生长因子β2(TGF-β2)。
J Surg Res. 2002 Apr;103(2):146-52. doi: 10.1006/jsre.2001.6350.
7
Factors in the pathogenesis of Dupuytren's contracture.掌腱膜挛缩症发病机制中的因素。
J Hand Surg Am. 2006 Nov;31(9):1527-34. doi: 10.1016/j.jhsa.2006.08.012.
8
Gelatinase A activity in Dupuytren's disease.杜普伊特伦挛缩症中的明胶酶A活性
J Hand Surg Am. 2006 Dec;31(10):1635-9. doi: 10.1016/j.jhsa.2006.08.007.
9
Feedback inhibition of high TGF-beta1 concentrations on myofibroblast induction and contraction by Dupuytren's fibroblasts.高浓度转化生长因子β1对掌腱膜成纤维细胞诱导肌成纤维细胞及收缩的反馈抑制作用
J Hand Surg Br. 2006 Oct;31(5):473-83. doi: 10.1016/j.jhsb.2006.05.007. Epub 2006 Jul 26.
10
Expression of bone morphogenetic proteins by Dupuytren's fibroblasts.杜普伊特伦挛缩症成纤维细胞中骨形态发生蛋白的表达
J Hand Surg Am. 2004 Sep;29(5):809-14. doi: 10.1016/j.jhsa.2004.02.008.

引用本文的文献

1
Epidemiological analysis of patients with Dupuytren's disease.掌腱膜挛缩症患者的流行病学分析。
Rev Bras Ortop. 2017 Dec 14;53(1):10-14. doi: 10.1016/j.rboe.2017.12.003. eCollection 2018 Jan-Feb.
2
Dupuytren's Disease: Predicting Factors and Associated Conditions. A Single Center Questionnaire-Based Case-Control Study.掌腱膜挛缩症:预测因素及相关病症。一项基于问卷调查的单中心病例对照研究。
Arch Bone Jt Surg. 2017 Nov;5(6):384-393.
3
Dupuytren's disease and needle aponeurotomy: rupture of a deep common flexor tendon: A case report and literature review.
掌腱膜挛缩症与针刀腱膜切开术:深部指浅屈肌腱断裂:一例报告及文献综述
J Orthop Case Rep. 2016 Jul-Aug;6(3):88-90. doi: 10.13107/jocr.2250-0685.528.
4
GLYCOSAMINOGLYCANS AND PROTEOGLYCANS IN PALMAR FASCIA OF PATIENTS WITH DUPUYTREN.掌腱膜挛缩症患者掌腱膜中的糖胺聚糖和蛋白聚糖
Acta Ortop Bras. 2016 Mar-Apr;24(2):98-101. doi: 10.1590/1413-785220162402154342.
5
SNPs previously associated with Dupuytren's disease replicated in a North American cohort.先前与掌腱膜挛缩症相关的单核苷酸多态性在一个北美队列中得到了复制。
Clin Med Res. 2014 Dec;12(3-4):133-7. doi: 10.3121/cmr.2013.1199. Epub 2014 Feb 26.
6
Evaluation of a mitochondrial DNA mutation in maternally inherited and sporadic cases of Dupuytren disease.掌腱膜挛缩症母系遗传和散发病例中线粒体DNA突变的评估。
Clin Med Res. 2012 Aug;10(3):122-6. doi: 10.3121/cmr.2012.1063. Epub 2012 May 25.